NUTRITIONAL STATUS AND QUALITY OF LIFE OF PATIENTS WITH LYMPHOMA
Abstract
Introduction: Treatment of malignancies nowdays has to control the disease and to achieve an adequate quality of life. Malnutrition at diagnosis and treatment is not rare, but is not determined regularly.
Aim: Determination of the frequency of malnutrition during chemotherapy and analysis of the quality of life in relation to the characteristics of the patients and type of lymphoproliferative diseases.
Material and methods: The study included 30 men and 20 women treated at the Clinic for hematology KCS between November 2017 and February 2018 with lymphoproliferative disease on chemotherapy or immunochemotherapy. Malnutrition Nutritional Risk Screening 2002 (NRS 2002) and the Mini Nutritional Assessment (MNA) were used for the assessment of malnutrition. Quality of life was assessed by Fact-Lym.
Results: The average age of respondents was 53.5 (95% CI 49.8 to 57.2) years. 64% of all patients were on the initial treatment, 36% were in relapse. According to NRS 2002 questionnaire 23 (46%) patients were malnourished, and according to MNA 32 (64%) patients were malnourished. A significantly higher frequency of malnourished patients was in the group whose CRP ≥ 10 mg/l (p = 0.010 for NRS 2002 and p = 0.036 for MNA). All patients with ECOG PS ≥ 3 were malnourished according to MNA. The overall quality of life did not differ with respect to patient characteristics (gender, age < 70 vs ≥ 70 years, disease stage, indolent vs aggressive disease, ECOG PS ≤ 2 vs ≥ 3, NRS 2002 ≤ 2 vs ≥ 3, MNA ≤ 11 vs ≥ 12, CRP
< 10 vs ≥ 10 mg/l). A sub-category - physical condition was significantly various in a group of malnourished and non-malnourished patients estimated by NRS 2002 (p = 0.01).
Conclusion: Nutritional status of patients with lymphoproliferative disease on chemotherapy or immunochemotherapy is damaged in about half of patients. Quality of life, especially the physical condition was significantly worse in the group of malnourished patients.
References
Stojisavljević N, Marisavljević D. Pregled i klasifikacija limfoproliferativnih neoplazmi. U: Marisavljević D. i Mihaljević B autori. Klinička hematologija. Beograd: Zavod za udžbenike i nastavna sredstva; 2014.
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol. 1999; 10(12):1419-32.
Gomez-Candela C, Canales Albendea MA, Palma Milla S, de Paz Arias R, Diaz Gomez J, Rodriguez-Duran D, et al. Nutritional intervention in oncohematological patient. Nutr Hosp 2012; 27(3):669-80.
Rasheed S, Woods RT. An investigation into the association between nutritional status and quality of life in older people admitted to hospital. J Hum Nutr Diet 2014; 27(2):142-51.
Kondrup J, Allison SP, Elia M, Vellas B, Plauth M, Educational, et al. ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003; 22(4):415-21.
Kaiser MJ, Bauer JM, Ramsch C, Uter W, Guigoz Y, Cederholm T, et al. Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging. 2009; 13(9):782-8.
Gavazzi C, Colatruglio S, Sironi A, Mazzaferro V, Miceli R. Importance of early nutritional screening in patients with gastric cancer. Br J Nutr. 2011; 106(12):1773-8.
Bozzetti F, Mariani L, Lo Vullo S et al. The nutritional risk in oncology: a study of 1,453 cancer outpatients, Support Care Cancer 2012; 20:1919–1928
Bourdel-Marchasson I, Diallo A, Bellera C, Blanc-Bisson C, Durrieu J, Germain C, et al. One-Year Mortality in Older Patients with Cancer: Development and External Validation of an MNA-Based Prognostic Score. PloS one. 2016; 11(2):e0148523.
American Society for Parenteral and Enteral Nutrition Board of Directors Guidelines for the use of parenteral and enteralnutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr (2002), 26(1):1SA–138SA.
Norman K, Pichard C, Lochs H, Pirlich M. Prognostic impact of disease-related malnutrition. Clin Nutr. 2008; 27(1):5-15.
Hlubocky F, Webster K, Cashy J, Beaumont J, Cella D. The Development and Validation of a Measure of Health-Related Quality of Life for Non-Hodgkin’s Lymphoma: The Functional Assessment of Cancer Therapy—Lymphoma (FACT-Lym) Lymphoma 2013; 2013:9.
Salas S, Mercier S, Moheng B, Olivet S, Garcia ME, Hamon S, et al. Nutritional status and quality of life of cancer patients needing exclusive chemotherapy: a longitudinal study. Health and quality of life outcomes. 2017; 15(1):85.
Fayers P, Bottomley A, Group EQoL, Quality of Life U. Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer. 2002; 38 Suppl 4:S125-33.
Tong H, Isenring E, Yates P. The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer. 2009; 17(1):83-90.
Marin Caro MM, Laviano A, Pichard C. Nutritional intervention and quality of life in adult oncology patients. Clin Nutr. 2007; 26(3):289-301.